2 hours Keros Therapeutics (NASDAQ:KROS) Now Covered by ScotiabankMarketBeat
Scotiabank started coverage on shares of Keros Therapeutics in a research report on Wednesday. They set a “sector outperform” rating on the stock.
Nasdaq 100 · Science · Scotiabank
X